Alise Reicin, Vice President Clinical Research, Merck & Co.

Engelwood, NJ

Current Site Of Practice: Merck & Co.
Hospital Affiliation: Merck & Co.
Focus of Research: Expression Of Oncogenes In Preleukemic Stages Of Retrovirus Induced T-Cell Leukemias In Akr Mice.
Fellowship Year: 1984 – 1985
Attended: Harvard Medical School